Investors Sell Shares of UnitedHealth Group Incorporated (UNH) on Strength (UNH)

Investors sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading on Wednesday. $107.02 million flowed into the stock on the tick-up and $154.05 million flowed out of the stock on the tick-down, for a money net flow of $47.03 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $0.58 for the day and closed at $195.26

A number of analysts have weighed in on UNH shares. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. BidaskClub raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 8th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 28th. Bank of America Corporation boosted their target price on shares of UnitedHealth Group from $210.00 to $214.00 and gave the stock a “buy” rating in a research note on Friday, July 14th. Finally, Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Three analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $203.59.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same quarter last year, the firm earned $1.96 EPS. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.56%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the transaction, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 76,174 shares of company stock worth $14,981,909. 0.89% of the stock is owned by insiders.

Hedge funds have recently added to or reduced their stakes in the stock. Honeywell International Inc. bought a new position in shares of UnitedHealth Group during the 1st quarter valued at $35,262,000. Schwab Charles Investment Management Inc. grew its holdings in shares of UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares during the last quarter. Suntrust Banks Inc. grew its holdings in shares of UnitedHealth Group by 8.5% during the 1st quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock valued at $42,774,000 after purchasing an additional 20,541 shares during the last quarter. Factory Mutual Insurance Co. grew its holdings in shares of UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after purchasing an additional 72,000 shares during the last quarter. Finally, Shell Asset Management Co. grew its holdings in shares of UnitedHealth Group by 0.8% during the 2nd quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock valued at $29,156,000 after purchasing an additional 1,254 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This story was first reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.truebluetribune.com/2017/10/13/investors-sell-shares-of-unitedhealth-group-incorporated-unh-on-strength-unh-2.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply